H&R GmbH & Co. KGaA (DE:2HRA)
XETRA:2HRA
Want to see DE:2HRA full AI Analyst Report?
2HRA Stock Chart & Stats
€4.36
-€0.07(-1.87%)
At close: 4:00 PM EST
€4.36
-€0.07(-1.87%)
Day’s Range― - ―
52-Week Range€3.91 - €5.04
Previous CloseN/A
Volume1.36K
Average Volume (3M)2.84K
Market Cap
€178.66M
Enterprise Value€240.81M
Total Cash (Recent Filing)€75.41M
Total Debt (Recent Filing)€136.06M
Price to Earnings (P/E)―
Beta0.38
Next Earnings
Aug 14, 2026EPS Estimate
0.13Next Dividend Ex-DateN/A
Dividend Yield2.27%
Share Statistics
EPS (TTM)-0.99
Shares Outstanding37,221,745
10 Day Avg. Volume1,415
30 Day Avg. Volume2,840
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.43
Price to Sales (P/S)0.13
P/FCF Ratio4.25
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€3.60Price Target Upside-17.43% Downside
Rating ConsensusModerate Sell
Number of Analyst Covering1
EPS Forecast (FY)0.25
Revenue Forecast (FY)€1.26B
Bulls Say, Bears Say
Bulls Say
Cash GenerationSustained operating cash flow (€126M TTM) and substantial free cash flow (€68.9M) create durable liquidity to fund capex, pay down debt, and support working capital. This cash strength cushions the business against cyclical earnings swings and enables strategic reinvestment.
Balance Sheet / LeverageA debt-to-equity ratio near 0.49 implies conservative leverage for a capital-intensive refiner/chemicals firm. Manageable debt relative to equity preserves financial flexibility for capex or downturns, reducing refinancing risk and allowing tactical responses to market cycles.
Integrated Specialty Chemicals ModelVertical integration from refining to specialty chemicals and tailored B2B product sales creates structural advantages: ability to capture feedstock spreads, shift mix toward higher-margin specialties, and maintain sticky industrial/customer relationships versus commodity-only peers.
Bears Say
Revenue & Margin PressureFalling revenue and materially compressed gross margins weaken intrinsic earnings power. Lower margins reduce the buffer against feedstock and energy cost swings, limit room for reinvestment, and make profitability highly sensitive to product mix and cyclical demand.
Return To Net Losses / Negative ROEA return to net losses and a negative ROE (~-9.1% TTM) signal that the balance sheet is not currently generating shareholder returns. Sustained losses can erode equity, constrain dividends or buybacks, and limit ability to fund growth without external capital.
Top-line Decline & Earnings VolatilityDouble-digit revenue decline and extreme EPS contraction indicate volatile demand and margin outcomes. Reliance on commodity-linked product lines and sensitivity to feedstock prices make earnings recovery uncertain and increase execution risk for sustained growth.
H&R GmbH & Co. KGaA News
2HRA FAQ
What was H&R GmbH & Co. KGaA’s price range in the past 12 months?
H&R GmbH & Co. KGaA lowest stock price was €3.91 and its highest was €5.04 in the past 12 months.
What is H&R GmbH & Co. KGaA’s market cap?
H&R GmbH & Co. KGaA’s market cap is €178.66M.
When is H&R GmbH & Co. KGaA’s upcoming earnings report date?
H&R GmbH & Co. KGaA’s upcoming earnings report date is Aug 14, 2026 which is in 54 days.
How were H&R GmbH & Co. KGaA’s earnings last quarter?
Currently, no data Available
Is H&R GmbH & Co. KGaA overvalued?
According to Wall Street analysts H&R GmbH & Co. KGaA’s price is currently Overvalued.
Does H&R GmbH & Co. KGaA pay dividends?
H&R GmbH & Co. KGaA pays a Annually dividend of €0.1 which represents an annual dividend yield of 2.27%. See more information on H&R GmbH & Co. KGaA dividends here
What is H&R GmbH & Co. KGaA’s EPS estimate?
H&R GmbH & Co. KGaA’s EPS estimate is 0.13.
How many shares outstanding does H&R GmbH & Co. KGaA have?
H&R GmbH & Co. KGaA has 37,221,745 shares outstanding.
What happened to H&R GmbH & Co. KGaA’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of H&R GmbH & Co. KGaA?
Currently, no hedge funds are holding shares in DE:2HRA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
H&R GmbH & Co. KGaA Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
32.69%
12-Months-Change
Fundamentals
Return on Equity
-9.29%
Trailing 12-Months
Asset Growth
-6.72%
Trailing 12-Months
Company Description
H&R GmbH & Co. KGaA
H&R GmbH & Co. KGaA is a German enterprise specializing in the production and distribution of chemical-pharmaceutical raw materials and precision plastic components, manufactured through injection molding. The company's operations are structured into three primary segments: ChemPharm Refining, ChemPharm Sales, and Plastics. The ChemPharm Refining division is responsible for manufacturing and supplying a diverse array of refined products, including paraffins, white oils, plasticizers, base oils, lubricants, and other specialized crude oil derivatives, as well as feedstocks and bunker fuels. Concurrently, the ChemPharm Sales segment focuses on the processing and commercialization of products such as plasticizers, wax emulsions, paraffins, and similar crude oil-based specialty items. The Plastics division is dedicated to the development, production, and sale of high-precision plastic parts tailored for industries like medical technology, automotive, and various other sectors. H&R's extensive product portfolio also encompasses petroleum jellies, different types of motor and process oils, cable filling compounds, ozone protection waxes, raw materials for the cosmetic and pharmaceutical sectors, mineral oils, and construction insulation materials. Founded in 1919 and headquartered in Salzbergen, Germany, the company transitioned its name to H&R GmbH & Co. KGaA in August 2016, having previously operated as H&R Aktiengesellschaft. It functions as a subsidiary of H&R Komplementär GmbH.
2HRA Stock 12 Month Forecast
Average Price Target
€3.60
▼(-17.43% Downside)
Technical Analysis
Options Prices
Currently, No data available
---